Despite affirming this highly significant association in the present study, we show that histomorphologic assessment is not particularly sensitive in screening for the BRAF V600E mutation given the subjectivity in recognizing these eosinophilic cells.
← all excerpts
<i>BRAF<sup>V600E</sup></i> -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma.
1
—
—